Novartis AG (NVSEF) Net income 2016–2025
Novartis AG (NVSEF) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$14.0BFY2025 · since FY2016: $6.7B → $14.0B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $14.0B | +17.1% |
| FY2024 | $11.9B | -19.6% |
| FY2023 | $14.8B | +113.5% |
| FY2022 | $7.0B | -71.0% |
| FY2021 | $24.0B | +197.6% |
| FY2020 | $8.1B | -31.2% |
| FY2019 | $11.7B | -7.0% |
| FY2018 | $12.6B | +63.7% |
| FY2017 | $7.7B | +14.8% |
| FY2016 | $6.7B | — |
Source: SEC XBRL filings · For reference only · Not investment advice